Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials...
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers.
Target Price
The average target price of LFCR is 9.5 and suggests 8% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation su
Buy
Sell